In conclusion, our results demonstrated that disturbed adiponectin–sphingolipid signaling is implicated in the etiology of the lipotoxic environment of diabetic cardiomyopathy in relation to oxidative stress, inflammation, and apoptotic cell death. Here, ADIPOQ is linked to diabetic cardiomyopathy.